1334040-33-3

Upstream product

• 1334047-55-0 C₃₇H₅₈O₁₀ 
• 1334041-90-5 C₃₇H₆₀O₁₀ 
• 287930-73-8 4-benzyl-2-hydroxy-morpholin-3-one 
• 1334038-02-6 (3β,15α,16α,17R,23R,24S)-24-(acetyloxy)-16,23-epoxy-16,25-hydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-15-ol 
• 1334037-98-7 (3β,16α,17R,23R,24S)-24-(acetyloxy)-16,23-epoxy-25-hydroxy-3-(β-D-xylopyranosyloxy)-9,19-cyclolanostan-15-one 
• 78213-32-8 24-O-acetylhydroshengmanol 3-[beta]-D-xylopyranoside(delta16,17)-enol ether 

Relevant academic research and scientific papers

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

The present invention provides compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein each of the variables listed above are as defined and described herein, compositions thereof, and methods of using the same.

COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS

As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.